ArticleJCEM case reports2026
Small bowel obstruction from metastatic small intestinal neuroendocrine tumor managed solely with somatostatin analog.
Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Small intestinal neuroendocrine tumors (SI-NETs) are an uncommon cause of bowel obstruction and are often diagnosed at an advanced stage. When SI-NETs are diagnosed in older patients, clinicians often face challenges that limit the use of evidence-based therapeutic interventions. In the presented case, an older patient with poor functional status presented with bowel obstruction. A biopsy obtained by diagnostic laparoscopy confirmed well-differentiated metastatic NET. The patient was considered at high risk for surgery. The patient and her proxy preferred conservative management. A trial of somatostatin analog (SSA) resulted in the improvement of bowel obstruction symptoms and decreased the size of the tumor in subsequent imaging studies. This case demonstrates the utility of SSA as a primary therapeutic intervention for resolving small bowel obstruction in patients with SI-NETs who are poor surgical candidates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.